Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Effects of Raloxifene on Bone Quality
NCT00532428Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2003
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of raloxifene in osteoporosis, sponsored by Eli Lilly and Company. Started Apr 2003; status: completed.
02
Drugs
raloxifene
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00532428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532428.